Morgan Stanley’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,638,076
| Closed | -$59.1M | – | 8410 |
|
|
2021
Q4 | $59.1M | Buy |
3,638,076
+57,554
| +2% | +$843K | 0.01% | 1221 |
|
|
2021
Q3 | $54.4M | Sell |
3,580,522
-549,012
| -13% | -$8.58M | 0.01% | 1241 |
|
|
2021
Q2 | $71.4M | Buy |
4,129,534
+382,757
| +10% | +$7.04M | 0.01% | 1058 |
|
|
2021
Q1 | $73.1M | Buy |
3,746,777
+578,391
| +18% | +$11.9M | 0.01% | 936 |
|
|
2020
Q4 | $63.3M | Buy |
3,168,386
+2,995,724
| +1,735% | +$61.2M | 0.01% | 940 |
|
|
2020
Q3 | $3.1M | Buy |
172,662
+90,530
| +110% | +$2.22M | ﹤0.01% | 3221 |
|
|
2020
Q2 | $2.22M | Buy |
82,132
+41,760
| +103% | +$1.15M | ﹤0.01% | 3503 |
|
|
2020
Q1 | $998K | Sell |
40,372
-118,068
| -75% | -$4.3M | ﹤0.01% | 3952 |
|
|
2019
Q4 | $8.26M | Buy |
158,440
+118,838
| +300% | +$5.44M | ﹤0.01% | 2636 |
|
|
2019
Q3 | $1.58M | Buy |
39,602
+24,295
| +159% | +$1.12M | ﹤0.01% | 3985 |
|
|
2019
Q2 | $731K | Sell |
15,307
-15,087
| -50% | -$608K | ﹤0.01% | 4404 |
|
|
2019
Q1 | $1.67M | Sell |
30,394
-81,912
| -73% | -$3.9M | ﹤0.01% | 3736 |
|
|
2018
Q4 | $4.09M | Sell |
112,306
-21,015
| -16% | -$860K | ﹤0.01% | 3121 |
|
|
2018
Q3 | $6.61M | Sell |
133,321
-3,927
| -3% | -$200K | ﹤0.01% | 2880 |
|
|
2018
Q2 | $6.07M | Buy |
137,248
+29,816
| +28% | +$1.23M | ﹤0.01% | 2928 |
|
|
2018
Q1 | $4.3M | Buy |
107,432
+29,431
| +38% | +$1.17M | ﹤0.01% | 3180 |
|
|
2017
Q4 | $3.12M | Buy |
78,001
+34,055
| +77% | +$1.31M | ﹤0.01% | 3604 |
|
|
2017
Q3 | $1.54M | Buy |
43,946
+7,141
| +19% | +$96.9K | ﹤0.01% | 4109 |
|
|
2017
Q2 | $534K | Sell |
36,805
-12,824
| -26% | -$161K | ﹤0.01% | 4757 |
|
|
2017
Q1 | $538K | Sell |
49,629
-23,211
| -32% | -$235K | ﹤0.01% | 4786 |
|
|
2016
Q4 | $885K | Sell |
72,840
-81,483
| -53% | -$895K | ﹤0.01% | 4555 |
|
|
2016
Q3 | $1.76M | Buy |
154,323
+153,450
| +17,577% | +$1.42M | ﹤0.01% | 3592 |
|
|
2016
Q2 | $7K | Sell |
873
-1,707
| -66% | -$16.7K | ﹤0.01% | 6170 |
|
|
2016
Q1 | $24K | Buy |
2,580
+96
| +4% | +$962 | ﹤0.01% | 5869 |
|
|
2015
Q4 | $37K | Sell |
2,484
-41,751
| -94% | -$561K | ﹤0.01% | 5832 |
|
|
2015
Q3 | $597K | Buy |
44,235
+29,380
| +198% | +$530K | ﹤0.01% | 4494 |
|
|
2015
Q2 | $199K | Sell |
14,855
-12,553
| -46% | -$154K | ﹤0.01% | 5236 |
|
|
2015
Q1 | $300K | Buy |
27,408
+17,456
| +175% | +$197K | ﹤0.01% | 4973 |
|
|
2014
Q4 | $109K | Sell |
9,952
-12,041
| -55% | -$119K | ﹤0.01% | 5514 |
|
|
2014
Q3 | $202K | Buy |
21,993
+4,060
| +23% | +$46.2K | ﹤0.01% | 5140 |
|
|
2014
Q2 | $288K | Buy |
17,933
+4,566
| +34% | +$82.5K | ﹤0.01% | 4959 |
|
|
2014
Q1 | $304K | Buy |
13,367
+6,631
| +98% | +$216K | ﹤0.01% | 4882 |
|
|
2013
Q4 | $185K | Buy |
6,736
+5,173
| +331% | +$116K | ﹤0.01% | 5065 |
|
|
2013
Q3 | $23K | Sell |
1,563
-12,386
| -89% | -$166K | ﹤0.01% | 5270 |
|
|
2013
Q2 | $191K | Buy |
+13,949
| New | +$179K | ﹤0.01% | 4865 |
|
Morgan Stanley's ZGNX Position: Q1 2022 in Review
Morgan Stanley sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 3,638,076 shares — an estimated $59.1M sold.
Morgan Stanley first reported a position in ZGNX in Q2 2013 and held it in 35 quarters. The position peaked at $73.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Morgan Stanley reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- Morgan Stanley sold 3,638,076 Zogenix, Inc. shares in Q1 2022, an estimated $59.1M.
- Morgan Stanley first reported a position in Zogenix, Inc. in Q2 2013 and held it in 35 quarters.
- Morgan Stanley's Zogenix, Inc. position peaked at $73.1M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.